Vision and Mission

Preclinical drug development is a scarce and critical knowledge field in South Africa. The development and manufacturing of relevant medicines for infectious and chronic diseases relevant to our society within the financial constraints are challenging.  It requires that novel pharmaceutical products and biologicals such as vaccines are developed and produced locally. The Platform aims to meet the stringent regulatory requirements to comply with international pharmaceutical best practices and to deliver a world class service in preclinical drug evaluation.

Outcomes

• A complete value chain in the drugs/phytomedicines industry.  The NWU forms a starting point.
• South Africa will be in a position to respond timeously and more comprehensively to the need to produce therapies for African or “Third-World” diseases.
• An institution that is accessible to all scientists who may require such research services at reasonable cost.
• Protection of South African intellectual property (IP).
• The enhancement of the capability of South Africa to participate in cutting-edge research